Atopic dermatitis treatment method

Details Atopic dermatitis treatment method Atopic dermatitis treatment method

2005-01-04

2005-01-04

Carlson, Karen Cochrane (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S012200, C424S450000, C604S019000, C604S020000, C604S290000, C607S049000, C530S350000, C530S300000

Reexamination Certificate

active

06838429

ABSTRACT:
Compositions are provided for treating atopic dermatitis, other atopic diseases and other inflammatory or allergic skin disorders. The compositions include proteins from Molluscum Contagiosum Virus (MCV), or fragments, variants, analogs, and derivatives thereof which exhibit AD inhibiting activity. Examples of MCV proteins which exhibit AD inhibiting activity include MC148P1, MC148P2, MC148P3, other MC148P type proteins, and fragments, variants, analogs, and derivatives of MC148P1, MC148P2, MC148P3, and other MC148P type proteins which possess AD inhibiting activity. The fragments, variants, analogs and derivatives may be less than 100% homologous to MCV proteins so long as they are sufficiently homologous such that AD inhibiting activity is preserved.

REFERENCES:
patent: 5573503 (1996-11-01), Untereker et al.
patent: 5733269 (1998-03-01), Fuisz
patent: WO 9909178 (1999-02-01), None
patent: WO 9934818 (1999-07-01), None
Krathwohl et al., PNAS, vol. 94, pp. 9875-9880, 1997.

Affiliated with

Also associated with

Rating

Atopic dermatitis treatment method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Atopic dermatitis treatment method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atopic dermatitis treatment method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3399520